Regeneron
-$2.38 (-0.43%) Today
$0.00 (0.00%) As of 10:33 PM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Regeneron and other ETFs, options, and stocks.
About REGN
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP.
CEO
Leonard S. Schleifer
Employees
9,123
Headquarters
Tarrytown, New York
Founded
1988
REGN Key Statistics
Market Cap
59.17B
Price-Earnings Ratio
9.98
Dividend Yield
—
Average Volume
809.80K
High Today
$558.20
Low Today
$552.16
Open Price
$557.33
Volume
828.58K
52 Week High
$686.62
52 Week Low
$441.00
REGN News
BenzingaOct 14
Why Regeneron Shares Are Rising Today
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) is trading higher Thursday after the company announced the FDA accepted for priority review a Biologics License App
Analyst Ratings
64%
of 25 ratings
Buy
64%
Hold
36%
Sell
0%
REGN Earnings
$0.00
$8.60
$17.20
$25.80
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Available Nov 4, Pre-Market
